Purdue Pharma Claims $10B Opioid Settlement, Files For Chapter 11 Bankruptcy

(September 16, 2019, 11:01 AM EDT) -- NEW YORK — OxyContin maker Purdue Pharma L.P. on Sept. 15 announced that it has reached an agreement in principle to settle its opioid litigation for more than $10 billion and...
To view the full article, register now.